Latest News

Treatments for coronavirus: Repurposing existing drugs

Why develop new drugs to combat the replication of the coronavirus if existing approved substances could do the same thing? Repurposing drugs in this fashion could offer a faster remedy against pathogens that have as yet received little research. A team of researchers led by Thomas F Meyer at the Max Planck Institute for Infection Biology in Berlin want to use this principle to test clinically approved drugs against the novel coronavirus.

Source link

Related posts

EMMAC Life Sciences Limited: £11 million Raised via Successful Private Placing


STAT Plus: Pharmalittle: Teva faces setback in new migraine drug market; prices for valsartan jump in the U.S.


Appeals court rejects hospital industry’s challenge on 340B changes


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy